China News Service, Yantai, July 29th (Wang Jiaoni) On the 29th, at the 2021 International Conference on Pharmaceutical Innovation and Development in Yantai, Shandong, academicians and experts jointly explored the innovation and development of Chinese medicine
academician At present, China's biomedicine development has entered a new stage, and the research and development of new drugs is developing rapidly, and the gap with the international level is gradually narrowing, especially the new crown vaccine research and development is in the world's first square
academician China Ke Xueyuan Academy of Sciences , National Center for Drug Research and Development expert committee will be members of the Chen Kaixian we believe that with the Chinese medicine industry, a group of biomedical science and technology innovation enterprise can flourish, and gradually have the ability to carry out pre-standardized clinical and clinical studies of new drugs, which will affect And change the pattern of new drug research in China
Academy Fellow committee members Chen Kaixian also mentioned that while paying attention to international frontier hotspots, we must give full play to the advantages of Chinese characteristics.
China Kexue Yuan Academy of Sciences , Chinese Center for Disease Control and Prevention, the main Rengao Fu noted that China's new crown vaccine research and development in the first phalanx of the world, Chinese scientists sequenced the genome of the virus results in time-sharing, for a time for the vaccine research and development around the world
Academician of the Academy of Sciences "If the world does not share the vaccine, the virus will share the world
China Kexue Yuan academician , Chinese Kexue Yuan researcher at the Institute of Biophysics Chan Yun Sang said that in the person's genetic code, non-coding nucleic acid has a very important function
Academician of the Academy of Sciences It is reported that in the first half of this year, China approved 21 innovative drugs, including new coronavirus vaccines and urgently-needed clinical drugs in the fields of tumors, immune system diseases, and rare diseases, setting a new record for the review of innovative drugs
Focus on the new crown pneumonia epidemic
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
